Blood · 2004 · 82 citations · 31 references
Life SciencesCell BiologyImmunologyCellular ImmunologyClinical ImmunologyTransplant ImmunologyAlloantigen RecognitionCell CharacterizationFlow CytometryT Cell ActivationT Cell BiologyT Cell DifferentiationAllogeneic T Cell ActivationAlloreactive T Cell RegulationAlloreactive T Cell ResponsesFlow Cytometry ImmunophenotypingT Cell AllorecognitionT Cell Effector FunctionsT Cell Functional AssaysT Cell Immunology
Human T-cell alloreactivity plays an important role in many disease processes, including the rejection of solid organ grafts and graft-versus-host disease (GVHD) following allogeneic stem cell transplantation. To develop a better understanding of the T cells involved in alloreactivity in humans, we developed a cytokine flow cytometry (CFC) assay that enabled us to characterize the phenotypic and functional characteristic of T cells responding to allogeneic stimuli. Using this approach, we determined that most T-cell alloreactivity resided within the CD4(+) T-cell subset, as assessed by activation marker expression and the production of effector cytokines (eg, tumor necrosis factor alpha [TNF]alpha) implicated in human GVHD. Following prolonged stimulation in vitro using either allogeneic stimulator cells or viral antigens, we found that coexpression of activation markers within the CD4(+) T-cell subset occurred exclusively within a subpopulation of T cells that significantly increased their surface expression of CD4. We then developed a simple sorting strategy that exploited these phenotypic characteristics to specifically deplete alloreactive T cells while retaining broad specificity for other stimuli, including viral antigens and third-party alloantigens. This approach also was applied to specifically enrich or deplete human virus-specific T cells.
31
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Edith M. Janssen, Edward E. Lemmens, Tom Wolfe et al. · Nature · 2003 · 1.6K citations
A Direct Estimate of the Human αβ T Cell Receptor Diversity
T. Petteri Arstila, Armanda Casrouge, Véronique Baron et al. · Science · 1999 · 943 citations
Bone Marrow Transplantation for Chronic Myelogenous Leukemia in Chronic Phase
John M. Goldman, Robert Peter Gale, Mary M. Horowitz et al. · Annals of Internal Medicine · 1988 · 863 citations
Medicine, Hematology, Oncology +13
S L Waldrop, Christine J. Pitcher, D. M. Peterson et al. · Journal of Clinical Investigation · 1997 · 549 citations · Full text